Our Services
Medical Information
Helpful Resources
Published on: 5/19/2026
Sin Nombre virus homes in on lung tissue by binding to β3 integrin receptors on pulmonary capillary endothelial cells, where it replicates and triggers immune-mediated vascular leakage and pulmonary edema characteristic of Hantavirus Pulmonary Syndrome. Infection occurs when aerosolized rodent excreta are inhaled, allowing the virus to enter deep lung airways and infect endothelial cells.
There are several factors to consider about transmission, early symptoms, prevention, and when to seek care. See below for complete details that could impact your next steps.
The Sin Nombre virus (SNV) is a hantavirus first identified in the southwestern United States in 1993. It is the most common cause of Hantavirus Pulmonary Syndrome (HPS) in North America. While infection is relatively rare, SNV can be severe and even fatal without prompt medical care. This guide explains how Sin Nombre virus transmission occurs, why the strain homes in on lung tissue, and what you can do to reduce risk.
Understanding Sin Nombre virus transmission is key to preventing infection. Here's how it typically happens:
SNV has a strong predilection for the lung's small blood vessels (capillaries). Several factors contribute:
Receptor Binding
Endothelial Cell Infection
Immune Response and Vascular Leakage
High Vascular Surface Area
Early symptoms of HPS can mimic common viral illnesses. Acting quickly can save lives. Watch for:
As the disease progresses, you may notice:
If you develop any serious respiratory symptoms—especially after potential rodent exposure—seek emergency medical care immediately.
You can reduce your risk of SNV exposure by taking simple precautions:
If you experience any concerning respiratory symptoms—especially after possible exposure to rodent droppings—contact a healthcare provider right away. Because persistent lung symptoms can indicate various serious conditions, you may want to learn more about Pulmonary Fibrosis and use a free symptom checker to better understand your symptoms before your medical appointment.
Remember, if you have questions or concerns about your health—especially anything that could be life-threatening—speak to a doctor as soon as possible.
(References)
* Maciejewski, C. A., & Saavedra-Rodriguez, K. (2018). Mechanisms of lung injury during hantavirus pulmonary syndrome. *American Journal of Physiology-Lung Cellular and Molecular Physiology*, *314*(5), L741-L750. PMID: 29543477.
* Saavedra-Rodriguez, K., Cifuentes, M. V., & Botten, J. (2019). The Hantavirus Replication Cycle and Mechanisms of Pathogenesis. *Viruses*, *11*(6), 551. PMID: 31137946.
* Peters, C. J., Maciejewski, C. A., & Saavedra-Rodriguez, K. (2014). Hantaviruses and endothelial cells: a deadly dance. *PLoS Pathogens*, *10*(11), e1004472. PMID: 25424844.
* Schmaljohn, C. S. (2020). Hantavirus pulmonary syndrome: an update. *Current Opinion in Virology*, *41*, 1-6. PMID: 32623351.
* Jayr, C., & Botten, J. W. (2013). Hantavirus pulmonary syndrome: novel insights into disease pathogenesis and molecular mechanisms. *Frontiers in Immunology*, *4*, 322. PMID: 24194723.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.